AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32972066 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study 35767198 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 dosage formula recommended dose based on renal function
Number of subjects: 686
Study 35767198 — intervention group
Group type: COMPARATOR
Intervention: Control group (ED and UD)
Number of subjects: 686
Study 33027217 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory Muscle Training (RMT)
Number of subjects: 44
Study 33027217 — intervention group
Group type: COMPARATOR
Intervention: Standard Rehabilitation (SR)
Number of subjects: 44
Study 33152781 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation to a web‐based self‐test for rehabilitation needs (n=4000)
Number of subjects: 8000
Study 33152781 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=4000)
Number of subjects: 8000
Study 32663760 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal doxorubicin (Caelyx®)
Number of subjects: 0
Study 33749084 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus salivarius subs. salicinius AP‐32, Lactobacillus paracasei ET‐66, Lactobacillus plantarum LPL28)
Number of subjects: 50
Study 33749084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 33274370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) 1 × 10^10 CFU twice daily for 5 days
Number of subjects: 813
Study 33274370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 813
Study 34272183 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 0
Study 34272183 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 0
Study 34272183 — intervention group
Group type: COMPARATOR
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 0
Study 35025543 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session cognitive-behavioral therapy (CBT)
Number of subjects: 952
Study 35025543 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session twelve-step facilitation (TSF)
Number of subjects: 952
Study 35025543 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-session motivational enhancement therapy (MET)
Number of subjects: 952
Study 35025543 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance in TSF and MET
Number of subjects: 952
Study 35025543 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance in CBT
Number of subjects: 952
Study 33132156 — intervention group
Group type: EXPERIMENTAL
Intervention: High-speed circuit resistance training (HSCT) for 8 weeks, three times per week.
Number of subjects: 20
Study 33132156 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) did not perform formal training.
Number of subjects: 20
Study 33132156 — intervention group
Group type: EXPERIMENTAL
Intervention: High-speed circuit resistance training (HSCT) group.
Number of subjects: 20
Study 36233462 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypopressive exercise program (moderate intensity, 12 weeks duration)
Number of subjects: 0
Study 36233462 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34347634 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson Relaxation Technique
Number of subjects: 70
Study 34347634 — intervention group
Group type: COMPARATOR
Intervention: Routine Care
Number of subjects: 70
Study 35951067 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong intervention (the 'white ball' system) taught by a traditional Chinese medicine specialist for 4 weeks followed by 4 weeks of self-practice
Number of subjects: 44
Study 35951067 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 44
Study 34039341 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected HPV test (SC-HPV) followed by pap smear (PS) in case of positivity
Number of subjects: 687
Study 34039341 — intervention group
Group type: COMPARATOR
Intervention: Pap smear (PS)
Number of subjects: 687
Study 32738222 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-point risk score incorporating four pre-transplant variables (age, dialysis dependence, serum bilirubin level, mechanical ventilation)
Number of subjects: 1388
Study 32738222 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk scores of four points or higher
Number of subjects: 1388
Study 32738222 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 1388
Study 32738222 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted regression analysis
Number of subjects: 1388
Study 32738222 — intervention group
Group type: EXPERIMENTAL
Intervention: Brier score of the composite score in the validation cohort
Number of subjects: 1388
Study 34871101 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (docetaxel, cisplatin, and fluorouracil) followed by surgery
Number of subjects: 68
Study 34871101 — intervention group
Group type: COMPARATOR
Intervention: Upfront surgery (segmental resection) followed by adjuvant treatment
Number of subjects: 68
Study 33831980 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual care training including transcendental meditation (T.M) technique for 4 weeks
Number of subjects: 54
Study 33831980 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study 35272722 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.37 g MFE in boiled rice
Number of subjects: 84
Study 35272722 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 g MFE in boiled rice
Number of subjects: 84
Study 35272722 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.12 g MFE in boiled rice
Number of subjects: 84
Study 35272722 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g MFE in rice porridge
Number of subjects: 84
Study 35272722 — intervention group
Group type: COMPARATOR
Intervention: 0 g MFE (control) in boiled rice
Number of subjects: 84
Study 35983514 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplement with IS (iodized salt)
Number of subjects: 3805
Study 35983514 — intervention group
Group type: EXPERIMENTAL
Intervention: ISFP (IS + iodine-rich food + iodine preparations)
Number of subjects: 3805
Study 35983514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary iodine intake from food, IS, and drinking water
Number of subjects: 3805
Study 35983514 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid nodule prevalence
Number of subjects: 3805
Study 35983514 — intervention group
Group type: EXPERIMENTAL
Intervention: TPOAb positive prevalence
Number of subjects: 3805
Study 33612587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cookies with WF:CP:CLF ratio of 49:49:2
Number of subjects: 15
Study 33612587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cookies with varying ratios of WF:CP:CLF (50:50:0, 49:49:2, 48:48:4, 47:47:6, 46:46:8)
Number of subjects: 15
Study 33612587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cookies with varying ratios of WF:CP:CLF
Number of subjects: 15
Study 37584046 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross myofascial release (MFR) along with conventional physical therapy
Number of subjects: 40
Study 37584046 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 40
Study 33661430 — intervention group
Group type: EXPERIMENTAL
Intervention: RAGT + VR (n = 30)
Number of subjects: 45
Study 33661430 — intervention group
Group type: COMPARATOR
Intervention: RAGT - VR (n = 15)
Number of subjects: 45
Study 32252250 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-GI bar (GI = 45)
Number of subjects: 8
Study 32252250 — intervention group
Group type: COMPARATOR
Intervention: High-GI bar (GI = 101)
Number of subjects: 8
Study 32078383 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up intervention
Number of subjects: 264
Study 32078383 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal depressive symptoms
Number of subjects: 264
Study 32078383 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal depressive symptoms
Number of subjects: 264
Study 33942447 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared medical appointments (SMAs)
Number of subjects: 6
Study 32330945 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV intervention
Number of subjects: 227
Study 32330945 — intervention group
Group type: COMPARATOR
Intervention: Health promotion intervention
Number of subjects: 227
Study 34559182 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessing another experiencing a reaction
Number of subjects: 530
Study 34559182 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher affective empathy
Number of subjects: 530
Study 34559182 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cognitive empathy
Number of subjects: 530
Study 32039973 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (VitC)
Number of subjects: 11330
Study 32039973 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine (THMN)
Number of subjects: 11330
Study 32039973 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C + Thiamine (VitC+THMN)
Number of subjects: 11330
Study 36615910 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed protein groups (milk/egg/peanut/cashew/almond/shrimp/walnut/wheat/salmon/hazelnut at low, medium, or high doses)
Number of subjects: 180
Study 36615910 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut group
Number of subjects: 180
Study 36615910 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 36615910 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture high group
Number of subjects: 180
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Intranasal corticosteroids (INCS)
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Combination intranasal antihistamine/INCS
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Intranasal antihistamines
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Oral antihistamine
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Sublingual immunotherapy tablets (SLIT-tablets)
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Montelukast
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Intranasal corticosteroids (INCS) for PAR
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Sublingual immunotherapy tablets (SLIT-tablets) for PAR
Number of subjects: 0
Study 34463311 — intervention group
Group type: COMPARATOR
Intervention: Oral antihistamine for PAR
Number of subjects: 0
Study 631198515 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe WMH (Fazekas scores 5-6)
Number of subjects: 1040
Study 631198515 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe SDWMH
Number of subjects: 1040
Study 631198515 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate WMH (Fazekas scores 3-4)
Number of subjects: 1040
Study 631198515 — intervention group
Group type: EXPERIMENTAL
Intervention: PVWMH
Number of subjects: 1040
Study 35773272 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation combining sound and tongue stimulation
Number of subjects: 0
Study 35773272 — intervention group
Group type: COMPARATOR
Intervention: Tongue stimulation combined with only pure tones (without background wideband noise)
Number of subjects: 0
Study 35773272 — intervention group
Group type: EXPERIMENTAL
Intervention: Only sound stimuli during the first 6 weeks, bimodal stimulation in the second 6 weeks
Number of subjects: 0
Study 33976374 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroprocaine 2%
Number of subjects: 211
Study 33976374 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.75%
Number of subjects: 211
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting with 120 µm Al2 O3 particles
Number of subjects: 63
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: 9% hydrofluoric acid
Number of subjects: 63
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 1 W
Number of subjects: 63
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 2 W
Number of subjects: 63
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 3 W
Number of subjects: 63
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 4 W
Number of subjects: 63
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 5 W
Number of subjects: 63
Study 33002287 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 6 W
Number of subjects: 63
Study 33002287 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 63
Study 32043193 — intervention group
Group type: COMPARATOR
Intervention: Axillary dissection (AD) arm
Number of subjects: 856
Study 32043193 — intervention group
Group type: EXPERIMENTAL
Intervention: MDA nomogram estimated risk
Number of subjects: 856
Study 32043193 — intervention group
Group type: EXPERIMENTAL
Intervention: MSK nomogram estimated risk
Number of subjects: 856
Study 36149682 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care (PC) intervention
Number of subjects: 57
Study 36149682 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control arm)
Number of subjects: 57
Study 33763720 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) for 8 weeks
Number of subjects: 82
Study 33763720 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet)
Number of subjects: 82
Study 36250492 — intervention group
Group type: EXPERIMENTAL
Intervention: Varus alignment (VrA) ≤ 3° valgus
Number of subjects: 159
Study 36250492 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral alignment (NA) 3‐9° valgus
Number of subjects: 159
Study 36250492 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus alignment (VlA) ≥ 9° valgus
Number of subjects: 159
Study 36250492 — intervention group
Group type: COMPARATOR
Intervention: All groups (VrA, NA, VlA)
Number of subjects: 159
Study 33832307 — intervention group
Group type: EXPERIMENTAL
Intervention: Huayu Jianpi Fangshi decoction
Number of subjects: 60
Study 33832307 — intervention group
Group type: COMPARATOR
Intervention: Huayu Fangshi placebo decoction
Number of subjects: 60
Study 34041842 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help version of the New Forest Parenting Programme (NFPP-SH)
Number of subjects: 12
Study 34844605 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted, theory-informed interventions
Number of subjects: 42
Study 34844605 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical leads
Number of subjects: 42
Study 34844605 — intervention group
Group type: EXPERIMENTAL
Intervention: Other educational materials and audit and feedback
Number of subjects: 42
Study 34844605 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical leads' perceptions
Number of subjects: 42
Study 36129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment with plate and screws
Number of subjects: 207
Study 36129720 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 207
Study 36129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 207
Study 36129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (subgroup of mechanically ventilated patients)
Number of subjects: 207
Study 32654580 — intervention group
Group type: EXPERIMENTAL
Intervention: OLNP-05
Number of subjects: 60
Study 32654580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33508690 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim Buprenorphine Treatment (IBT)
Number of subjects: 16
Study 33508690 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 16
Study 34995935 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine supplementation (10 g/day for 9 days)
Number of subjects: 65
Study 34995935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 33256760 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 267
Study 33256760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 33470630 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-tiered classification based on CT appearance and duration postsurgery; training group outcomes: I=10.5 d, II=24 d, III=66.5 d, IV=72 d; P=0.005.
Number of subjects: 59
Study 33470630 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-tiered classification; risk of salvage resection increased with grade 4 (risk ratio=9); P=0.043.
Number of subjects: 59
Study 33470630 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-tiered classification; complication severity increased; P=0.027.
Number of subjects: 59
Study 33470630 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group outcomes; risk of salvage resection; P=0.007.
Number of subjects: 59
Study 33470630 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group outcomes; hospital stay; P=0.001.
Number of subjects: 59
Study 33470630 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group outcomes; complications; P=0.016.
Number of subjects: 59
Study 33137517 — intervention group
Group type: EXPERIMENTAL
Intervention: ACUTENS
Number of subjects: 42
Study 33137517 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 42
Study 33137517 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study 36168187 — intervention group
Group type: EXPERIMENTAL
Intervention: asciminib (40 mg twice-daily)
Number of subjects: 16
Study 36168187 — intervention group
Group type: COMPARATOR
Intervention: bosutinib (500 mg once daily)
Number of subjects: 16
Study 34661454 — intervention group
Group type: EXPERIMENTAL
Intervention: Ripretinib at a dose of 150 mg once a day
Number of subjects: 0
Study 34661454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34383534 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose methylphenidate (0.6 mg/kg/dose)
Number of subjects: 75
Study 34383534 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose methylphenidate (0.3 mg/kg/dose)
Number of subjects: 75
Study 34383534 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of methylphenidate
Number of subjects: 75
Study 34383534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 32212340 — intervention group
Group type: EXPERIMENTAL
Intervention: R-lipoic acid (LA) 600 mg
Number of subjects: 20
Study 32212340 — intervention group
Group type: COMPARATOR
Intervention: R,S-lipoic acid (LA) 1200 mg
Number of subjects: 20
Study 35086075 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta-low gamma (LG) phase amplitude coupling (PAC) during successful trials of the incongruent condition
Number of subjects: 8
Study 35086075 — intervention group
Group type: COMPARATOR
Intervention: Group analysis of theta-LG PAC
Number of subjects: 8
Study 32005419 — intervention group
Group type: EXPERIMENTAL
Intervention: Femaxeen
Number of subjects: 81
Study 32005419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 36038001 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of a balanced mixture of amino acids (2 g/kg ideal body weight/day)
Number of subjects: 3500
Study 36038001 — intervention group
Group type: COMPARATOR
Intervention: Placebo (balanced crystalloid solution)
Number of subjects: 3500
Study 33561870 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative opioid education
Number of subjects: 237
Study 33561870 — intervention group
Group type: COMPARATOR
Intervention: No preoperative opioid education (Control)
Number of subjects: 237
Study 33561870 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Preoperative education and Control)
Number of subjects: 237
Study 35176163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib plus docetaxel (docetaxel 60 mg/m2 every 21 days plus ribociclib 400 mg/day on days 1-4 and 8-15 with filgrastim on days 5-7)
Number of subjects: 43
Study 35176163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib plus docetaxel
Number of subjects: 43
Study 33785752 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day fast followed by a modified Dietary Approach to Stop Hypertension diet
Number of subjects: 0
Study 33785752 — intervention group
Group type: COMPARATOR
Intervention: Modified Dietary Approach to Stop Hypertension diet alone
Number of subjects: 0
Study 32243049 — intervention group
Group type: EXPERIMENTAL
Intervention: Blepharoplasty with peeling (Phenol 89%)
Number of subjects: 30
Study 32243049 — intervention group
Group type: COMPARATOR
Intervention: Blepharoplasty without peeling
Number of subjects: 30
Study 34237809 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazilian boys
Number of subjects: 2250
Study 34237809 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazilian girls
Number of subjects: 2250
Study 34237809 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazilian youth
Number of subjects: 2250
Study 36478631 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified simulated patient experience
Number of subjects: 127
Study 36478631 — intervention group
Group type: COMPARATOR
Intervention: Video simulated learning
Number of subjects: 127
Study 36478631 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified simulated patient as second activity
Number of subjects: 127
Study 36478631 — intervention group
Group type: COMPARATOR
Intervention: Video learning as second activity
Number of subjects: 127
Study 33398481 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic management of femoroacetabular impingement (FAI)
Number of subjects: 154
Study 35124742 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual telephone-based extended-care
Number of subjects: 410
Study 35124742 — intervention group
Group type: EXPERIMENTAL
Intervention: Group telephone-based extended-care
Number of subjects: 410
Study 35124742 — intervention group
Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 410
Study 34641819 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling sessions based on motivational interviewing (MI), 5 sessions during a 12-week outpatient pulmonary rehabilitation program.
Number of subjects: 43